Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective.

@article{Mittendorf2008PersonalAE,
  title={Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective.},
  author={Thomas Mittendorf and Birgitta Dietz and Raimund Sterz and Mary A Cifaldi and Hartmut Kupper and J Matthias Graf von der Schulenburg},
  journal={Rheumatology},
  year={2008},
  volume={47 2},
  pages={188-93}
}
OBJECTIVES This study evaluated the patients' perspective of burden of disease among 505 patients with severe, long-standing rheumatoid arthritis receiving adalimumab. METHODS Health-related quality-of-life and resource use data were collected during a 144-week open-label study. RESULTS Adalimumab maintained pain control and reduced the duration of morning stiffness. Work impairment decreased and work productivity was maintained over the duration of the study. Costs were estimated at… CONTINUE READING

From This Paper

Topics from this paper.
24 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…